CYP46A1 Suppression for Tau-Mediated Neurodegeneration
h-var-1dc420e7d8
## Mechanistic Overview
CYP46A1 Suppression for Tau-Mediated Neurodegeneration starts from the claim that modulating CYP46A1 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The therapeutic suppression of cholesterol 24-hydroxylase (CYP46A1) represents a novel approach to treating tau-med
Elo ratings (across arenas)
| Arena | Rating | RD | W-L-D | N |
|---|---|---|---|---|
| neurodegeneration | 1355 | ±242 | 0-3-0 | 3 |
Ancestry (oldest → this)
mutate · gen 1
parent: h-2600483e
Descendants
(no variants yet)